
Flow Cytometry Buffer can be used for the immunofluorescent staining of single-cell suspensions prepared from either lymphoid tissues, bone marrow, peripheral blood, or cultured cells. Stain Buffer (FBS) is useful for the dilution and application of fluorescent reagents as well as for the suspension, washing, and storage of cells destined for flow cytometric analysis.
The global Flow Cytometry Buffer market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Flow Cytometry Buffer 91ÖÆÆ¬³§.
The Flow Cytometry Buffer market is driven by several factors that contribute to the adoption and growth of these specialized solutions in flow cytometry applications. Some key drivers include:
Sample Preservation: Flow cytometry buffers are formulated to maintain the viability and integrity of cells or particles during the staining and analysis process. Proper buffer selection helps preserve the characteristics of the sample for accurate analysis.
Cell Stabilization: Buffers are used to stabilize cells and prevent clumping or aggregation, ensuring uniform dispersion and accurate analysis in flow cytometry experiments.
Cell Permeabilization: Some flow cytometry assays require cell permeabilization to allow fluorescent probes to access intracellular targets. Specialized permeabilization buffers enable the penetration of dyes into cells without compromising their structural integrity.
Antibody Binding: Buffers are designed to optimize the binding of fluorescently labeled antibodies to target cells, enabling precise identification and analysis of specific cell populations.
Blocking Unspecific Binding: Flow cytometry buffers can include blocking agents that prevent nonspecific binding of antibodies and reagents to cells, reducing background noise and improving data accuracy.
Buffer pH and Ionic Strength: Proper pH and ionic strength are crucial for maintaining cellular structure and the performance of fluorescent dyes. Buffers help maintain the physiological conditions required for accurate analysis.
Instrument Compatibility: Manufacturers develop flow cytometry buffers that are optimized for specific flow cytometry instruments, ensuring compatibility and reliable results.
Multiparametric Analysis: Buffers enable the simultaneous analysis of multiple parameters, such as cell size, granularity, and fluorescence intensity, allowing researchers to gather comprehensive data from single-cell analysis.
Standardization: Flow cytometry buffers are formulated following established protocols and quality control measures, ensuring consistent and reproducible results across different experiments and labs.
Rising Research and Clinical Applications: Flow cytometry is widely used in both research and clinical settings for cell analysis, diagnosis, and monitoring. The increasing adoption of flow cytometry across various disciplines drives the demand for specialized buffers.
Advancements in Antibody Labeling: As fluorescent labeling techniques improve, the need for compatible buffers that maximize antibody binding and fluorescent signal detection also grows.
Drug Discovery and Development: Flow cytometry plays a crucial role in drug discovery, target identification, and toxicity testing. Buffers ensure accurate analysis of cell responses to compounds and drugs.
Immunology and Cancer Research: Flow cytometry is pivotal in immunology and cancer research for analyzing immune cell subsets and detecting specific markers. Buffers are essential to obtain reliable data in these studies.
Diagnostic Applications: Flow cytometry is used for clinical diagnostics, including immunophenotyping and monitoring disease progression. Accurate analysis depends on suitable buffers.
Technological Advancements: Ongoing advancements in flow cytometry instrumentation and fluorescent dyes drive the need for buffers optimized for new technologies and applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Flow Cytometry Buffer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Agilent Technologies
Sartorius AG
BD
Merck Millipore
Beckman Coulter
Siemens Healthcare
Sysmex
BioLegend
Miltenyi Biotec
Tonbo Biosciences
Segment by Type
Surface Staining Buffer
Fixation Buffer
Viability Staining Buffer
Others
Segment by Application
Academic and Research Institutes
Hospitals and Clinical Testing Laboratories
Pharmaceutical and Biotechnology Companies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Flow Cytometry Buffer report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Flow Cytometry Buffer Market Overview
1.1 Product Overview and Scope of Flow Cytometry Buffer
1.2 Flow Cytometry Buffer Segment by Type
1.2.1 Global Flow Cytometry Buffer Market Value Comparison by Type (2023-2029)
1.2.2 Surface Staining Buffer
1.2.3 Fixation Buffer
1.2.4 Viability Staining Buffer
1.2.5 Others
1.3 Flow Cytometry Buffer Segment by Application
1.3.1 Global Flow Cytometry Buffer Market Value by Application: (2023-2029)
1.3.2 Academic and Research Institutes
1.3.3 Hospitals and Clinical Testing Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Global Flow Cytometry Buffer Market Size Estimates and Forecasts
1.4.1 Global Flow Cytometry Buffer Revenue 2018-2029
1.4.2 Global Flow Cytometry Buffer Sales 2018-2029
1.4.3 Global Flow Cytometry Buffer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Flow Cytometry Buffer Market Competition by Manufacturers
2.1 Global Flow Cytometry Buffer Sales Market Share by Manufacturers (2018-2023)
2.2 Global Flow Cytometry Buffer Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Flow Cytometry Buffer Average Price by Manufacturers (2018-2023)
2.4 Global Flow Cytometry Buffer Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Flow Cytometry Buffer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flow Cytometry Buffer, Product Type & Application
2.7 Flow Cytometry Buffer Market Competitive Situation and Trends
2.7.1 Flow Cytometry Buffer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Flow Cytometry Buffer Players Market Share by Revenue
2.7.3 Global Flow Cytometry Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Flow Cytometry Buffer Retrospective Market Scenario by Region
3.1 Global Flow Cytometry Buffer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Flow Cytometry Buffer Global Flow Cytometry Buffer Sales by Region: 2018-2029
3.2.1 Global Flow Cytometry Buffer Sales by Region: 2018-2023
3.2.2 Global Flow Cytometry Buffer Sales by Region: 2024-2029
3.3 Global Flow Cytometry Buffer Global Flow Cytometry Buffer Revenue by Region: 2018-2029
3.3.1 Global Flow Cytometry Buffer Revenue by Region: 2018-2023
3.3.2 Global Flow Cytometry Buffer Revenue by Region: 2024-2029
3.4 North America Flow Cytometry Buffer Market Facts & Figures by Country
3.4.1 North America Flow Cytometry Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Flow Cytometry Buffer Sales by Country (2018-2029)
3.4.3 North America Flow Cytometry Buffer Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flow Cytometry Buffer Market Facts & Figures by Country
3.5.1 Europe Flow Cytometry Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Flow Cytometry Buffer Sales by Country (2018-2029)
3.5.3 Europe Flow Cytometry Buffer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flow Cytometry Buffer Market Facts & Figures by Country
3.6.1 Asia Pacific Flow Cytometry Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Flow Cytometry Buffer Sales by Country (2018-2029)
3.6.3 Asia Pacific Flow Cytometry Buffer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Flow Cytometry Buffer Market Facts & Figures by Country
3.7.1 Latin America Flow Cytometry Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Flow Cytometry Buffer Sales by Country (2018-2029)
3.7.3 Latin America Flow Cytometry Buffer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flow Cytometry Buffer Market Facts & Figures by Country
3.8.1 Middle East and Africa Flow Cytometry Buffer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Flow Cytometry Buffer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Flow Cytometry Buffer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Flow Cytometry Buffer Sales by Type (2018-2029)
4.1.1 Global Flow Cytometry Buffer Sales by Type (2018-2023)
4.1.2 Global Flow Cytometry Buffer Sales by Type (2024-2029)
4.1.3 Global Flow Cytometry Buffer Sales Market Share by Type (2018-2029)
4.2 Global Flow Cytometry Buffer Revenue by Type (2018-2029)
4.2.1 Global Flow Cytometry Buffer Revenue by Type (2018-2023)
4.2.2 Global Flow Cytometry Buffer Revenue by Type (2024-2029)
4.2.3 Global Flow Cytometry Buffer Revenue Market Share by Type (2018-2029)
4.3 Global Flow Cytometry Buffer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Flow Cytometry Buffer Sales by Application (2018-2029)
5.1.1 Global Flow Cytometry Buffer Sales by Application (2018-2023)
5.1.2 Global Flow Cytometry Buffer Sales by Application (2024-2029)
5.1.3 Global Flow Cytometry Buffer Sales Market Share by Application (2018-2029)
5.2 Global Flow Cytometry Buffer Revenue by Application (2018-2029)
5.2.1 Global Flow Cytometry Buffer Revenue by Application (2018-2023)
5.2.2 Global Flow Cytometry Buffer Revenue by Application (2024-2029)
5.2.3 Global Flow Cytometry Buffer Revenue Market Share by Application (2018-2029)
5.3 Global Flow Cytometry Buffer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Flow Cytometry Buffer Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Agilent Technologies
6.2.1 Agilent Technologies Corporation Information
6.2.2 Agilent Technologies Description and Business Overview
6.2.3 Agilent Technologies Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Agilent Technologies Flow Cytometry Buffer Product Portfolio
6.2.5 Agilent Technologies Recent Developments/Updates
6.3 Sartorius AG
6.3.1 Sartorius AG Corporation Information
6.3.2 Sartorius AG Description and Business Overview
6.3.3 Sartorius AG Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sartorius AG Flow Cytometry Buffer Product Portfolio
6.3.5 Sartorius AG Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Flow Cytometry Buffer Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Merck Millipore
6.5.1 Merck Millipore Corporation Information
6.5.2 Merck Millipore Description and Business Overview
6.5.3 Merck Millipore Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck Millipore Flow Cytometry Buffer Product Portfolio
6.5.5 Merck Millipore Recent Developments/Updates
6.6 Beckman Coulter
6.6.1 Beckman Coulter Corporation Information
6.6.2 Beckman Coulter Description and Business Overview
6.6.3 Beckman Coulter Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beckman Coulter Flow Cytometry Buffer Product Portfolio
6.6.5 Beckman Coulter Recent Developments/Updates
6.7 Siemens Healthcare
6.6.1 Siemens Healthcare Corporation Information
6.6.2 Siemens Healthcare Description and Business Overview
6.6.3 Siemens Healthcare Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siemens Healthcare Flow Cytometry Buffer Product Portfolio
6.7.5 Siemens Healthcare Recent Developments/Updates
6.8 Sysmex
6.8.1 Sysmex Corporation Information
6.8.2 Sysmex Description and Business Overview
6.8.3 Sysmex Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sysmex Flow Cytometry Buffer Product Portfolio
6.8.5 Sysmex Recent Developments/Updates
6.9 BioLegend
6.9.1 BioLegend Corporation Information
6.9.2 BioLegend Description and Business Overview
6.9.3 BioLegend Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BioLegend Flow Cytometry Buffer Product Portfolio
6.9.5 BioLegend Recent Developments/Updates
6.10 Miltenyi Biotec
6.10.1 Miltenyi Biotec Corporation Information
6.10.2 Miltenyi Biotec Description and Business Overview
6.10.3 Miltenyi Biotec Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Miltenyi Biotec Flow Cytometry Buffer Product Portfolio
6.10.5 Miltenyi Biotec Recent Developments/Updates
6.11 Tonbo Biosciences
6.11.1 Tonbo Biosciences Corporation Information
6.11.2 Tonbo Biosciences Flow Cytometry Buffer Description and Business Overview
6.11.3 Tonbo Biosciences Flow Cytometry Buffer Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Tonbo Biosciences Flow Cytometry Buffer Product Portfolio
6.11.5 Tonbo Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flow Cytometry Buffer Industry Chain Analysis
7.2 Flow Cytometry Buffer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flow Cytometry Buffer Production Mode & Process
7.4 Flow Cytometry Buffer Sales and Marketing
7.4.1 Flow Cytometry Buffer Sales Channels
7.4.2 Flow Cytometry Buffer Distributors
7.5 Flow Cytometry Buffer Customers
8 Flow Cytometry Buffer Market Dynamics
8.1 Flow Cytometry Buffer Industry Trends
8.2 Flow Cytometry Buffer Market Drivers
8.3 Flow Cytometry Buffer Market Challenges
8.4 Flow Cytometry Buffer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fisher
Agilent Technologies
Sartorius AG
BD
Merck Millipore
Beckman Coulter
Siemens Healthcare
Sysmex
BioLegend
Miltenyi Biotec
Tonbo Biosciences
Ìý
Ìý
*If Applicable.
